IP Verse

Novartis Gene Therapies, Inc. et al. vs Genzyme Corporation et al.

The detailed information for PTAB case with proceeding number IPR2023-00609 filed by Novartis Gene Therapies, Inc. et al. against Genzyme Corporation et al. on Feb 22, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2023-00609
Filing Date: Feb 22, 2023
Petitioner: Novartis Gene Therapies, Inc. et al.
Respondent: Genzyme Corporation et al.
Status: Institution Denied
Respondent Application Number: 12661553
Respondent Tech Center: 1600
Respondent Patent Number: 9051542
Institution Decision Date: Aug 30, 2023
Termination Date: Aug 30, 2023

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice: refund approved	Oct 11, 2023	PAPER	BOARD
'542 Petitioner's Request for Refund	Oct 4, 2023	PAPER	PETITIONER
Institution Decision: Deny	Aug 30, 2023	PAPER	BOARD
'542 Petitioner's Updated Exhibit List	Aug 23, 2023	PAPER	PETITIONER
Novartis Exhibit 1028_263 - Memorandum Opinion Markman	Aug 23, 2023	EXHIBIT	PETITIONER
Patent Owner's Surreply to Petitioner's Reply to Patent Owner's Preliminary Response	Jul 19, 2023	PAPER	PATENT OWNER
Patent Owner Genzyme's Notice of Filing Exhibit: Teleconference Transcript of July 11, 2023	Jul 12, 2023	PAPER	PATENT OWNER
July 11, 2023 Teleconference Transcript	Jul 12, 2023	EXHIBIT	PATENT OWNER
'542 Petitioner's Reply to Patent Owner's Preliminary Response	Jul 12, 2023	PAPER	PETITIONER
Novartis Exhibit 1027_Sotera Stipulation	Jul 12, 2023	EXHIBIT	PETITIONER
Patent Owner's Preliminary Response	Jun 15, 2023	PAPER	PATENT OWNER
Declaration of Martyn C. Davies	Jun 15, 2023	EXHIBIT	PATENT OWNER
CV of Martyn Davis	Jun 15, 2023	EXHIBIT	PATENT OWNER
XIE-Large_Scale_Production	Jun 15, 2023	EXHIBIT	PATENT OWNER
Wright - Identification_of_Factors	Jun 15, 2023	EXHIBIT	PATENT OWNER
SMITH-Gene_Therapy	Jun 15, 2023	EXHIBIT	PATENT OWNER
KONZ-Develpment_of_a_Purification	Jun 15, 2023	EXHIBIT	PATENT OWNER
Stipulation & Order to Amend Case Schedule	Jun 15, 2023	EXHIBIT	PATENT OWNER
Defendants First Amended Invalidity Contentions	Jun 15, 2023	EXHIBIT	PATENT OWNER
Time to Trial	Jun 15, 2023	EXHIBIT	PATENT OWNER
Time to Trial 2	Jun 15, 2023	EXHIBIT	PATENT OWNER
Order denying Motion to Amend	Jun 15, 2023	EXHIBIT	PATENT OWNER
Statutory Disclaimer	Jun 15, 2023	EXHIBIT	PATENT OWNER
Patent Owner's Response to Novartis's Notice Regarding Multiple Petitions	Jun 15, 2023	PAPER	PATENT OWNER
Granting Patent Owner Unopposed Motion for Admission Pro Hac Vice of Katherine A. Helm 37 C.F.R. § 42.10	Jun 8, 2023	PAPER	BOARD
Corrected Declaration of Katherine A. Helm J.D., PH.D. In Support of Motion for Admission Pro Hac Vice	Jun 2, 2023	EXHIBIT	PATENT OWNER
Notice of Filing Corrected Declaration of Katherine A. Helm, J.D., PH.D. In Support of Motion for Admission Pro Hac Vice	Jun 2, 2023	PAPER	PATENT OWNER
EXPUNGED	May 26, 2023	PAPER	PATENT OWNER
EXPUNGED	May 26, 2023	EXHIBIT	PATENT OWNER
Patent Owner Genzyme Corporation's Unopposed Motion For Pro Hac Vice Admission of Katherine A. Helm, J.D., PH.D.	May 26, 2023	PAPER	PATENT OWNER
Declaration of Katherine A. Helm J.D., PH.D. In Support of Motion for Admission Pro Hac Vice	May 26, 2023	EXHIBIT	PATENT OWNER
Patent Owner's Updated Power of Attorney	May 2, 2023	PAPER	PATENT OWNER
Patent Owner's Updated Mandatory Notices	May 2, 2023	PAPER	PATENT OWNER
Petitioners’ Updated Mandatory Notices	Mar 16, 2023	PAPER	PETITIONER
Petitioners’ Corrected Exhibit List	Mar 16, 2023	PAPER	PETITIONER
Notice: Notice filing date accorded	Mar 15, 2023	PAPER	BOARD
Notice : Mandatory Notice	Mar 15, 2023	PAPER	PATENT OWNER
Notice : Power of Attorney	Mar 15, 2023	PAPER	PATENT OWNER
Novartis Exhibit 1001_USP 9051542	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1003_Evans PCT_WO 01_66137	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1004_Frei PCT_WO 99 41416A2	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1005_Huang 2000	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1006_Mingozzi 2002	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1007_Wright	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1008_Gatlin_Injectable Drug Development	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1009_Liu PCT_WO 03 039459A2	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1010_Lochrie PCT WO 03046142A2	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1011_Potter 2002	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1012_Clark 2002	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1013_Croyle	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1014_ABOUT_ definition in the Cambridge English Dictionary	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1015_USP 6261823	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1016_Freireich 1966	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1017_FDA 2005 Guidance	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1019_Johnson 1975	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1021_Remington Volume II	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1022_Handbook of Pharmaceutical Excipients	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1023_2023.01.24 DI 105 Joint Claim Const Brief-Public	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1026_USP 6146874	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1018_Carpenter 2002	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1020_Remington Volume I	Feb 22, 2023	EXHIBIT	PETITIONER
Novartis Exhibit 1024_Common Buffers and Stock Solutions	Feb 22, 2023	EXHIBIT	PETITIONER
’542 Petitioners’ Power of Attorney	Feb 22, 2023	PAPER	PETITIONER
Novartis Exhibit 1002_Prosecution History of USP 9051542	Feb 22, 2023	EXHIBIT	PETITIONER
Petition for Inter Partes Review of U.S. Patent No. 9,051,542	Feb 22, 2023	PAPER	PETITIONER
Novartis Exhibit 1025 Declaration of Mansoor Amiji	Feb 22, 2023	EXHIBIT	PETITIONER
’542 Petitioners’ Exhibit List	Feb 22, 2023	PAPER	PETITIONER
Petitioners’ Explanation of Multiple Petitions	Feb 22, 2023	PAPER	PETITIONER